Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-11-091374
Filing Date
2011-04-07
Accepted
2011-04-07 17:11:40
Documents
11
Period of Report
2011-04-07

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d6k.htm 6-K 11973
2 NOTICE OF ANNUAL GENERAL MEETING dex991.htm EX-99.1 6660
3 MANAGEMENT INFORMATION CIRCULAR DATED MARCH 24, 2011 dex992.htm EX-99.2 367382
4 FORM OF PROXY - ANNUAL GENERAL MEETING MAY 11, 2011 dex993.htm EX-99.3 13275
5 PROXY VOTING FORM dex994.htm EX-99.4 17973
6 GRAPHIC g167472ex99_4pg001.jpg GRAPHIC 64005
7 GRAPHIC g167472ex99_4pg002.jpg GRAPHIC 63622
8 GRAPHIC g167472g02p71.jpg GRAPHIC 14055
9 GRAPHIC g167472g12h11.jpg GRAPHIC 180543
10 GRAPHIC g167472g53r95.jpg GRAPHIC 58425
11 GRAPHIC g167472g57f36.jpg GRAPHIC 133812
  Complete submission text file 0001193125-11-091374.txt   1128003
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 11746878
SIC: 2834 Pharmaceutical Preparations